DECIDER (Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer) is a research project funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 965193 from February 1, 2021 to July 31, 2026
Company Details
- Industry
- Research
- Website
- https://www.deciderproject.eu/
- Competitors
- TEHDAS2 joint action, Faculty of Science, University of Southern Denmark, iCAN - Digital Precision Cancer Medicine, Surgical Oncology Society Pakistan (SOSPK), REMEDi4ALL, Center for Digital Narrative (CDN), CIHR Institute of Aging | Institut du vieillissement des IRSC, JPND - EU Joint-Programme Neurodegenerative Disease Research, RISER Project, Oslo Life Science Forum.
Decider Project Questions
Decider Project's website is https://www.deciderproject.eu/
Decider Project's LinkedIn profile is https://www.linkedin.com/company/decider-project
Decider Project's industry is
Research
Decider Project's top competitors are
Tehdas2 Joint Action,
Faculty Of Science, University Of Southern Denmark,
Ican - Digital Precision Cancer Medicine,
Surgical Oncology Society Pakistan (Sospk),
Remedi4all,
Center For Digital Narrative (Cdn),
Cihr Institute Of Aging | Institut Du Vieillissement Des Irsc,
Jpnd - Eu Joint-Programme Neurodegenerative Disease Research,
Riser Project,
Oslo Life Science Forum.
Decider Project's categories are Research
